Pulmonary Embolism Registry
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 主要终点
- Identification of Pulmonary Embolism (PE) risk factors and comorbidities
研究概览
简要总结
Acute Pulmonary Embolism (PE) is the most serious clinical presentation of venous thromboembolism (VTE), a leading cause of cardiovascular mortality, exceeded only by stroke and myocardial infarction. Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe chronic form of CTED and it occurs in 2-4% of patients after acute PE.
In Portugal little is known about PE epidemiology and its outcomes, including complications like CTED. The main goal of this study is, therefore, to understand PE epidemiology and complications in the northern region of Portugal. This information can enable the organization of a structured health care network that can potentially benefit all PE patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acute symptomatic or asymptomatic PE,
- •Age >18 years,
- •Availability of a minimum data set for PE and a minimum of 3-months follow-up for the primary objective and 36-months for the secondary one. Except for patients who died prior to the 3 or 36 months follow-up.
排除标准
- •Enrolment of the patient in any treatment trial in a blinded fashion,
- •Lack or withdrawal of patient´s consent.
结局指标
主要结局
Identification of Pulmonary Embolism (PE) risk factors and comorbidities
时间窗: From date of inclusion until the end of the study currently planned (3 to 5 years)
Frequency of risk factors and comorbidities
Determine Pulmonary Embolism (PE) prevalence in Portugal
时间窗: From date of inclusion until the end of the study currently planned (3 to 5 years)
Number cases per year
Determine Pulmonary Embolism (PE) clinical management.
时间窗: From date of inclusion until the end of the study currently planned (3 to 5 years)
Identification of diagnostic of diagnostic and treatment profile
次要结局
- Access incidence rate of Chronic Thromboembolic Disease (CTED) with or without pulmonary hypertension after acute PE.(From 6 months after date of inclusion until the end of the study currently planned (2 to 5 years))